FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625381567> ?p ?o ?g. }

• W2625381567 endingPage "61509" @default.
• W2625381567 startingPage "61499" @default.
• W2625381567 abstract "// Jian-Yong Sun 1, * , Zheng-Wei Zhao 1, * , Wei-Miao Li 1, 2, * , Guang Yang 1 , Peng-Yu Jing 1 , Pei Li 1 , Hai-Zhou Dang 1 , Zhao Chen 1 , Yong-An Zhou 1 and Xiao-Fei Li 1 1 Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China 2 Department of Respiration, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China * These authors have contributed equally to this work Correspondence to: Xiao-Fei Li, email: lixfchest@163.com Yong-An Zhou, email: chuyan22@fmmu.edu.cn Keywords: MALAT1, HUVECs, proliferation, miR-320a, FOXM1 Received: March 20, 2017     Accepted: May 21, 2017     Published: June 16, 2017 ABSTRACT Regulation of cancer angiogenesis could be a useful strategy in cancer therapy. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA (lncRNA), and can induce cancer cell proliferation, while lncRNAs, generally are able to act as microRNA (miRNA) sponges. The latter is a type of competitive endogenous RNA (ceRNA) that regulates expression of the targeting miRNAs and protein-coding genes. This study investigated the proliferative role of MALAT1 in human umbilical vein endothelial cells (HUVECs) and the underlying molecular events. The data showed that knockdown of MALAT1 expression using MALAT1 siRNA inhibited HUVEC proliferation and also significantly decreased levels of FOXM1 mRNA and protein in vitro , while knockdown of FOXM1 expression reduced HUVEC proliferation. Annotation of HUVEC microarray data revealed that seven miRNAs, including miR-320a, were upregulated after knockdown of MALAT1 expression in HUVECs. MALAT1 was shown to reciprocally interact with miR-320a, i.e., expression of one negatively regulated levels of the other, whereas knockdown of MALAT1 expression promoted miR-320a levels. Furthermore, miR-320a could directly target and inhibit FOXM1 expression in HUVECs. Knockdown of MALAT1 expression enhanced miR-320a expression but reduced FOXM1 expression resulting in downregulation of HUVEC proliferation. However, such an effect was inhibited by miR-320a depletion. In conclusion, this study demonstrates that miR-320a plays an important role in mediating the effects of MALAT1 on HUVEC proliferation by suppression of FOXM1 expression. Thus, targeting of this gene pathway could be a novel strategy in cancer therapy." @default.
• W2625381567 created "2017-06-23" @default.
• W2625381567 creator A5010520524 @default.
• W2625381567 creator A5012953028 @default.
• W2625381567 creator A5015283314 @default.
• W2625381567 creator A5021555728 @default.
• W2625381567 creator A5025270532 @default.
• W2625381567 creator A5034893058 @default.
• W2625381567 creator A5048168253 @default.
• W2625381567 creator A5048405268 @default.
• W2625381567 creator A5074265065 @default.
• W2625381567 creator A5075716358 @default.
• W2625381567 date "2017-06-16" @default.
• W2625381567 modified "2023-09-26" @default.
• W2625381567 title "Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression" @default.
• W2625381567 cites W1940272364 @default.
• W2625381567 cites W1978521623 @default.
• W2625381567 cites W1987202159 @default.
• W2625381567 cites W2067831604 @default.
• W2625381567 cites W2080476488 @default.
• W2625381567 cites W2087528029 @default.
• W2625381567 cites W2095514131 @default.
• W2625381567 cites W2137449882 @default.
• W2625381567 cites W2165673724 @default.
• W2625381567 cites W2334245120 @default.
• W2625381567 cites W2340743383 @default.
• W2625381567 cites W2398601466 @default.
• W2625381567 cites W2404824878 @default.
• W2625381567 cites W2416423710 @default.
• W2625381567 cites W2419326786 @default.
• W2625381567 cites W2469990829 @default.
• W2625381567 cites W2488747960 @default.
• W2625381567 cites W2492531936 @default.
• W2625381567 cites W2498632582 @default.
• W2625381567 cites W2520681140 @default.
• W2625381567 cites W2551878117 @default.
• W2625381567 cites W2552397829 @default.
• W2625381567 cites W2554396333 @default.
• W2625381567 cites W2557212572 @default.
• W2625381567 cites W2560126974 @default.
• W2625381567 cites W2561471982 @default.
• W2625381567 cites W2562358288 @default.
• W2625381567 cites W2563046503 @default.
• W2625381567 cites W2563849173 @default.
• W2625381567 cites W2565206604 @default.
• W2625381567 cites W2568502415 @default.
• W2625381567 cites W2581192729 @default.
• W2625381567 cites W2586263396 @default.
• W2625381567 cites W2587915185 @default.
• W2625381567 cites W2596884392 @default.
• W2625381567 cites W32449127 @default.
• W2625381567 cites W4234678029 @default.
• W2625381567 cites W893024720 @default.
• W2625381567 cites W3140180001 @default.
• W2625381567 doi "https://doi.org/10.18632/oncotarget.18507" @default.
• W2625381567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5617440" @default.
• W2625381567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28977880" @default.
• W2625381567 hasPublicationYear "2017" @default.
• W2625381567 type Work @default.
• W2625381567 sameAs 2625381567 @default.
• W2625381567 citedByCount "35" @default.
• W2625381567 countsByYear W26253815672017 @default.
• W2625381567 countsByYear W26253815672018 @default.
• W2625381567 countsByYear W26253815672019 @default.
• W2625381567 countsByYear W26253815672020 @default.
• W2625381567 countsByYear W26253815672021 @default.
• W2625381567 countsByYear W26253815672023 @default.
• W2625381567 crossrefType "journal-article" @default.
• W2625381567 hasAuthorship W2625381567A5010520524 @default.
• W2625381567 hasAuthorship W2625381567A5012953028 @default.
• W2625381567 hasAuthorship W2625381567A5015283314 @default.
• W2625381567 hasAuthorship W2625381567A5021555728 @default.
• W2625381567 hasAuthorship W2625381567A5025270532 @default.
• W2625381567 hasAuthorship W2625381567A5034893058 @default.
• W2625381567 hasAuthorship W2625381567A5048168253 @default.
• W2625381567 hasAuthorship W2625381567A5048405268 @default.
• W2625381567 hasAuthorship W2625381567A5074265065 @default.
• W2625381567 hasAuthorship W2625381567A5075716358 @default.
• W2625381567 hasBestOaLocation W26253815671 @default.
• W2625381567 hasConcept C104317684 @default.
• W2625381567 hasConcept C127561419 @default.
• W2625381567 hasConcept C145059251 @default.
• W2625381567 hasConcept C153911025 @default.
• W2625381567 hasConcept C173396325 @default.
• W2625381567 hasConcept C2779134362 @default.
• W2625381567 hasConcept C502942594 @default.
• W2625381567 hasConcept C54355233 @default.
• W2625381567 hasConcept C60365752 @default.
• W2625381567 hasConcept C62112901 @default.
• W2625381567 hasConcept C62203573 @default.
• W2625381567 hasConcept C71924100 @default.
• W2625381567 hasConcept C81885089 @default.
• W2625381567 hasConcept C86803240 @default.
• W2625381567 hasConceptScore W2625381567C104317684 @default.
• W2625381567 hasConceptScore W2625381567C127561419 @default.
• W2625381567 hasConceptScore W2625381567C145059251 @default.
• W2625381567 hasConceptScore W2625381567C153911025 @default.
• W2625381567 hasConceptScore W2625381567C173396325 @default.

• next